Stallergenes Moves to the Cloud with Veeva CRM
October 11, 2011BARCELONA, SPAIN — 11 October, 2011 – Stallergenes, the world leader in sublingual immunotherapy, has selected Veeva CRM to replace …
India will scrutinise foreign investment in pharma
October 11, 2011Manufacturing and Production, Research and Development, Sales and Marketing India, Indian pharmaceutical industry
The Indian government has decided not to put any restrictions on the level of foreign direct investment (FDI) in the …
Parexel to work with Singapore on clinical research training
October 11, 2011Research and Development Asia, CRO, Parexel, Singapore, clinical research
Parexel and the National University of Singapore have launched a new academic course to train Asia’s scientist to work in …
‘Paralysis’ in NHS if reforms passed
October 11, 2011Andrew Lansley, Health and Social Care Bill, Mike Farrar, NHS
A prominent NHS leader has warned the government’s reforms are unworkable in their current form. NHS Confederation chief executive Mike …
AstraZeneca plans $200m manufacturing plant in China
October 11, 2011Manufacturing and Production AstraZeneca, China, pharma manufacturing news
AstraZeneca has announced plans to set up a manufacturing facility in north-eastern China, backed by a record investment by the …
Pfizer taps into Saudi stimulus package with new plant
October 10, 2011Manufacturing and Production Pfizer, pharma manufacturing news
Pfizer has unveiled expansion plans for the Middle East region with an agreement to open a manufacturing plant in Saudi …
Novo Nordisk’s Victoza launched in China
October 10, 2011Sales and Marketing Byetta, China, Victoza, diabetes
Novo Nordisk’s Victoza is now available in China, one of the fastest growing diabetes markets in the world. Victoza (liraglutide …
US approval for Merck’s Januvia-Zocor combination
October 10, 2011Sales and Marketing Januvia, Juvisync, Zocor
US regulators have given the green light to the latest in Merck & Co’s stable of brands aimed at type …
Janssen launches Incivo in the UK
October 10, 2011Sales and Marketing Incivek, Incivo
Janssen’s new hepatitis C treatment Incivo has been launched in the UK, one of two new drugs set to advance …
Merck & Co chairman Richard Clark retires
October 10, 2011Research and Development, Sales and Marketing appointment, sales and marketing
Richard Clark will step down as chairman of Merck & Co on 1 December after leading the company for six …
NHS chiefs call for more honesty about service cuts
October 10, 2011NHS, NHS reforms
The NHS Confederation has called on the government to be more open about cuts to the health service. The government …
Latest Priorclave Compact Autoclave Design to
October 7, 2011Manufacturing and Production
Despite this comprehensive range of laboratory autoclaves there is always someone who wants something different and that is exactly what …
PRIORCLAVE AUTOCLAVES SHIP OUT EARLY TO AFRICA
October 7, 2011Manufacturing and Production
The order called for a total of seventy-two top-loading, 150L capacity steam sterilisers with high output/low power steam generators built-in. …
Delivering an effective forecasting process
October 7, 2011Sales and Marketing
It’s surprising how many companies struggle to deliver an effective forcasting process despite the millions spent on supply chains. Accurate …
Novo Nordisk sponsors haemophilia comic
October 7, 2011Medical Communications Novo Nordisk, haemophilia, medical communications news
Novo Nordisk is sponsoring an educational comic about haemophilia for young sufferers of the blood disorder in the UK. It …
The Scott Partnership acquires Phoenix Marcom
October 7, 2011Medical Communications Scott Partnership, medical communications agency
Cheshire-based The Scott Partnership has acquired Phoenix Marcom, boosting its reach into the European market. The Cambridge, UK scientific marketing …
Novartis cuts Lucentis price amid growing pressure
October 7, 2011Sales and Marketing Lucentis, wet AMD
Novartis has been forced to cut the Swiss price of its eye drug Lucentis by 30% after sharp negotiations with …
Boehringer signs away HIV rights to focus on hep C
October 7, 2011Research and Development Boehringer, Gilead, HIV, hepatitis C
Boehringer Ingelheim has signed a deal giving Gilead Sciences exclusive worldwide rights to a major part of its HIV portfolio. …
Mary Hicks joins TogoRun
October 7, 2011Medical Communications TOGORUN EUROPE ANNOUNCES SENIOR HIRE, appointment, medical communications
TogoRun has appointed Mary Hicks as a director at its London office.She joins the agency from Clew Communications, where she …
UK funding boost for early-stage research
October 7, 2011Research and Development NIHR, UK science
The government has established a new research institute to aid public and private groups working on the early stages of …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
